Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11021463 Therapeutic inhibitory compounds

Patent 11021463 was granted and assigned to Attune Pharmaceuticals, Inc on June, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+378 characters)
Article

Patent abstract

Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting plasma kallikrein. Furthermore, the subject compounds and compositions are useful for the treatment of diseases wherein the inhibition of plasma kallikrein inhibition has been implicated, such as angioedema and the like.

Edits on 10 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 10 Oct, 2023
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Andrew McDonald0
Shawn Qian0
Edits on 24 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=110214630
Edits on 5 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 5 Apr, 2023
Edits on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Edits on 1 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Attune Pharmaceuticals, Inc
Attune Pharmaceuticals, Inc
0
Current Assignee
Attune Pharmaceuticals, Inc
Attune Pharmaceuticals, Inc
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
110214630
Date of Patent
June 1, 2021
0
Patent Application Number
163734280
Date Filed
April 2, 2019
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=110214630
Patent Citations
‌
US Patent 10023557 Therapeutic inhibitory compounds
0
‌
US Patent 10266515 Therapeutic inhibitory compounds
0
‌
US Patent 10308637 Therapeutic inhibitory compounds
0
Patent Primary Examiner
‌
Kortney L. Klinkel
0
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11021463
Edits on 12 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 12 Feb, 2022
Edits made to:
Infobox (+12 properties)
‌

 US Patent 11021463 Therapeutic inhibitory compounds

Infobox
Is a
Patent
Patent
Patent applicant
Attune Pharmaceuticals, Inc
Attune Pharmaceuticals, Inc
Current assignee
Attune Pharmaceuticals, Inc
Attune Pharmaceuticals, Inc
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11021463
Date of patent
June 1, 2021
Patent application number
16373428
Date Filed
April 2, 2019
Patent citations
‌
US Patent 10023557 Therapeutic inhibitory compounds
‌
US Patent 10266515 Therapeutic inhibitory compounds
‌
US Patent 10308637 Therapeutic inhibitory compounds
Patent primary examiner
‌
Kortney L. Klinkel

Find more entities like US Patent 11021463 Therapeutic inhibitory compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo